Last reviewed · How we verify

NCT05707845: PMS

Effect of Weight Reduction and Aerobic Exercise on PMS Symptoms in Obese Females

Completed NA Last updated 11 June 2024
What this trial tests

NA trial testing Medical treatment. in Premenstrual Syndrome in 40 participants. Completed in 1 December 2023.

Timeline
1 May 2023
Primary endpoint
1 August 2023
1 December 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 May 2023
Primary completion1 August 2023
Estimated completion1 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 30, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study will be investigation of the effect of weight reduction and aerobic exercises on premenstrual syndrome symptoms in obese females.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Medical treatment.

Trials testing the same drug.

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05707845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing